Mark J. Ratain to Myeloablative Agonists
This is a "connection" page, showing publications Mark J. Ratain has written about Myeloablative Agonists.
Connection Strength
0.030
-
Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103). Cancer Chemother Pharmacol. 2014 Nov; 74(5):927-38.
Score: 0.030